Exelixis (EXEL) Tops Q2 EPS by 9c

Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.28, $0.09 better than the analyst estimate of $0.19. Revenue for the quarter came in at $419.4 million versus the consensus estimate of $390.44 million.

GUIDANCE:

Exelixis sees FY2022 revenue of $1.53-1.63 billion, versus the consensus of $1.59 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Premarket movers: Quest, Labcorp hit by CMS cuts
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'